According to the National Diabetes Statistics Report, 2017 nearly 2 million people in the United States are diagnosed with diabetes every year. In 2015 alone, an estimated 30 million Americans of all ages had diabetes.
There are two main types of diabetes. Type 1 and Type 2. Both of these cause blood glucose levels to be higher than normal, but the two different types do this in different ways. In Type 1, the body attacks insulin-producing cells in the pancreas, causing a rise in blood sugar levels. In Type 2, the more common form of diabetes, insufficient insulin is produced in the pancreas, which slows the metabolism and increases blood sugar levels.
Diabetes is a group of diseases that affect how your body uses blood sugar (glucose). Glucose is vital to your health because it’s an important source of energy for the cells that make up your muscles and tissues. It’s also your brain’s main source of fuel.
CBD could be used to treat diabetes, according to researchers at the Hebrew University of Jerusalem, led by Dr. Raphael Mechoulam, who is known as the leading expert on CBD.
Diabetes Studies
- The impact of marijuana use on glucose, insulin, and insulin resistance among US adults
- CBD attenuates cardiac dysfunction, oxidative stress, fibrosis, and inflammatory and cell death signaling pathways in diabetic cardiomyopathy
- CBD lowers incidence of diabetes in non-obese diabetic mice
- Neuroprotective and blood-retinal barrier-preserving effects of CBD in experimental diabetes
- Cannabidiol arrests onset of autoimmune diabetes in NOD mice
- Diabetic retinopathy: Role of inflammation and potential therapies for anti-inflammation
- Cannabinoids alter endothelial function in the Zucker rat model of type 2 diabetes
- The endocannabinoid system in obesity and type 2 diabetes
- Cannabinoids and endocannabinoids in metabolic disorders with a focus on diabetes
- The endocannabinoid system and plant-derived cannabinoids in diabetes and diabetic complications
- Cannabinoid-mediated modulation of neuropathic pain and microglial accumulation in a model of murine type I diabetic peripheral neuropathic pain
- Biochemical and immunohistochemical changes in delta-9-tetrahydrocannabinol-treated type 2 diabetic rats
- Efficacy and Safety of CBD and THC-V on Glycemic and Lipid Parameters in Patients With Type 2 Diabetes